Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 66 | 62 | 65 | 69 | 68 |
| Accounts receivable | 27 | -97 | 48 | -49 | -21 |
| Other Working Capital | 88 | -286 | 867 | 196 | -622 |
| Other Operating Activity | -868 | -702 | -1,329 | -672 | -797 |
| Operating Cash Flow | $-687 | $-1,023 | $-348 | $-457 | $-1,371 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -11 | -65 | -7 | -9 |
| Investing Cash Flow | $-15 | $-11 | $-65 | $-7 | $-9 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -29 | -29 | -29 | -48 | -23 |
| Common Stock Issued | 668 | 978 | 305 | 454 | 1,305 |
| Other Financing Activity | 98 | 0 | 0 | -2 | 0 |
| Financing Cash Flow | $737 | $949 | $275 | $404 | $1,281 |
| Beginning Cash Position | 46 | 132 | 269 | 330 | 428 |
| End Cash Position | 81 | 46 | 132 | 269 | 330 |
| Net Cash Flow | $35 | $-85 | $-137 | $-61 | $-99 |
| Free Cash Flow | |||||
| Operating Cash Flow | -687 | -1,023 | -348 | -457 | -1,371 |
| Capital Expenditure | -15 | -11 | -65 | -7 | -9 |
| Free Cash Flow | -702 | -1,034 | -412 | -464 | -1,380 |